146 related articles for article (PubMed ID: 6419237)
1. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
Uotila P; Matintalo M; Dahl ML
Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
[TBL] [Abstract][Full Text] [Related]
2. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
3. OKY-1581: a selective inhibitor of thromboxane synthesis in vivo and in vitro.
Smith JB; Jubiz W
Prostaglandins; 1981 Sep; 22(3):353-63. PubMed ID: 7302264
[TBL] [Abstract][Full Text] [Related]
4. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelet aggregation and thromboxane production by pinacidil.
Goodman RP; Little DM; Wright JT
Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
[TBL] [Abstract][Full Text] [Related]
6. Lithium stimulates thromboxane B2 formation in human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
[TBL] [Abstract][Full Text] [Related]
7. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
[TBL] [Abstract][Full Text] [Related]
8. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
Shikano M; Ito T; Ogawa K; Satake T
Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
[TBL] [Abstract][Full Text] [Related]
9. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
Punnonen K; Uotila P; Mäntylä E
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
[TBL] [Abstract][Full Text] [Related]
10. Effect of OKY-046, a selective thromboxane inhibitor, on prostaglandin production and function of pregnant rat uteri and platelets.
Ghodgaonkar RB; Dubin NH
Prostaglandins Leukot Med; 1987 Jan; 26(1):33-46. PubMed ID: 3468521
[TBL] [Abstract][Full Text] [Related]
11. Evidence for isosorbide dinitrate (ISDN) promoting effect on prostacyclin release by the lung and prostacyclin implication in ISDN-induced inhibition of platelet aggregation in humans.
Rolland PH; Bory M; Leca F; Sainsous J; Gueydon E; Juhan I; Serradimigni A; Cano JP
Prostaglandins Leukot Med; 1984 Dec; 16(3):333-46. PubMed ID: 6396656
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
Uotila P; Matintalo M
Prostaglandins Leukot Med; 1984 Apr; 14(1):41-6. PubMed ID: 6427791
[TBL] [Abstract][Full Text] [Related]
13. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane B2, 6-keto-PGF1 alpha, PGE2, PGF2 alpha, and PGA1 plasma levels in arteriosclerosis obliterans: relationship to clinical manifestations, risk factors, and arterial pathoanatomy.
Jouve R; Rolland PH; Delboy C; Mercier C
Am Heart J; 1984 Jan; 107(1):45-52. PubMed ID: 6581715
[TBL] [Abstract][Full Text] [Related]
15. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
Morimoto K; Ikata T; Tounai T
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
[TBL] [Abstract][Full Text] [Related]
17. Effects of experimental diabetes on spontaneous contractions, on the output of prostaglandins and on the metabolism of labelled arachidonic acid, in uteri isolated from ovariectomized rats. Influences of estradiol.
Franchi AM; Chaud M; Gonzalez ET; Gimeno MA; Gimeno AL
Prostaglandins; 1988 Feb; 35(2):191-205. PubMed ID: 3129757
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
[TBL] [Abstract][Full Text] [Related]
19. Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
Mikashima H; Ochi H; Muramoto Y; Yasuda H; Tsuruta M; Maruyama Y
Thromb Res; 1986 Aug; 43(4):455-68. PubMed ID: 3094191
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
